1 year
1 Year
Adarsh Kesharwani pursuing Ph.D. in Pharmacology from GLA University, Mathura India, and recently he has submitted his thesis in August 2025, specializing in the neuroprotective and antioxidant roles of trans-zeatin in Parkinson’s disease. With over 1 years of academic and research experience, he has worked extensively on ferroptosis associated Parkinson’s disease, Nrf2/HO-1 pathway and natural product-based therapeutic interventions. Before that he has completed his Masters in Pharmacology from Dr. APJ. Abdul Kalam Technical University, where he has developed a strong interest in neurodegenerative diseases. He is currently associated with Galgotia College of Pharmacy, where he contribute(s) to teaching, mentoring, and advancing pharmacological research. He has published more than 4 research papers, 12 review papers, and 4 book chapters in peer-reviewed journals and presented work at national and international conferences. He has also completed various workshops on Cell culture techniques, MTT assay, PCR, Electrophoresis, RNA and DNA isolation, and flow cytometry. Kesharwani has established expertise in antioxidant assays (DPPH, NO, and hydroxyl radical scavenging), in vitro and in vivo Parkinson’s disease models, and mechanisms involving NRF2/HO-1 signaling and ferroptosis mitigation. He aims to bridge natural product drug discovery with translational neuroscience